HealthEquity, Inc.

Fundamentals7.0
Price Action4.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Strong Cash Flow
  • Solid Liquidity
  • Intangible Exposure

AI
AI Summary

6.0

HQY's investment case has shifted to a high-quality cash-flow and margin-expansion story, but at ~33x earnings investors should wait for evidence that efficiency gains and interest-related income are durable before adding aggressively; downside risk rises if rates, HSA asset growth, or guidance momentum soften.

MarginExpansion
ValuationRisk
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • •Strong Cash Flow
  • •Solid Liquidity
  • •Intangible Exposure

HQY delivers strong profitability, cash flow, and liquidity, but high intangible-asset exposure, meaningful debt, and premium valuation warrant caution.

CashGenerative
PremiumValuation

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Seller control
  • •Support stabilization
  • •Resistance overhead

HQY is bearish over the last month but stabilizing near $92.66–$93.36 support, with a recovery signal above $97.00–$98.80 and renewed downside risk below support.

HQY
TechnicalAnalysis
Support Level: $92.66–$93.36
Resistance Level: $97.00–$98.80

Sharp drop from above $105 in late

Sentiment & News

7.0

Key News Insights:

  • •Earnings Beat
  • •Margin Expansion
  • •Institutional Buying

HealthEquity beat Q2 estimates, lifted outlook on HSA growth and margin gains, but modest guidance and cybersecurity risk may temper near-term stock upside.

HealthEquity
HSA

Strong operating momentum supports a positive long-term outlook, though limited guidance upside could constrain near-term gains